Literature DB >> 10862771

Prostaglandin H synthase. Effects of peroxidase cosubstrates on cyclooxygenase velocity.

B Bambai1, R J Kulmacz.   

Abstract

Many cosubstrates for the peroxidase activity of prostaglandin H synthase-1 (PGHS-1) have been reported to produce a large (2-7-fold) increase in the cyclooxygenase velocity in addition to a substantial increase in the number of cyclooxygenase catalytic turnovers. The large stimulation of cyclooxygenase velocity has become an important criterion for evaluation of putative PGHS reaction mechanisms. This criterion has been a major weakness of branched-chain tyrosyl radical mechanisms, which correctly predict many other cyclooxygenase characteristics. Our computer simulations based on a branched-chain mechanism indicated that the uncorrected oxygen electrode signals commonly used to monitor activity can seriously overestimate the effects of cosubstrate on cyclooxygenase velocity. The simulation results prompted re-examination of the effect of several cosubstrates (phenol, acetaminophen, N,N,N',N'-tetramethylphenylenediamine, and Trolox) on PGHS-1 cyclooxygenase velocity. Cyclooxygenase kinetics were examined at reduced temperature or elevated pH, where the oxygen electrode signal can be corrected to provide reliable oxygen consumption trajectories. The cosubstrates produced only a slight (10-60%) stimulation of the cyclooxygenase velocity. Peroxidase cosubstrates thus have a much smaller stimulatory effect on cyclooxygenase velocity than previously reported. This corrects a longstanding misperception of cosubstrate effects, provides more realistic kinetic constraints on PGHS mechanisms, and removes what was a major deficiency of branched-chain tyrosyl radical mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862771     DOI: 10.1074/jbc.M003982200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

2.  Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.

Authors:  Benjamin J Orlando; Michael G Malkowski
Journal:  J Biol Chem       Date:  2016-05-20       Impact factor: 5.157

3.  Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.

Authors:  R Pouplana; J J Lozano; C Pérez; J Ruiz
Journal:  J Comput Aided Mol Des       Date:  2002-10       Impact factor: 3.686

Review 4.  Prostaglandin H synthase: resolved and unresolved mechanistic issues.

Authors:  Ah-Lim Tsai; Richard J Kulmacz
Journal:  Arch Biochem Biophys       Date:  2009-09-01       Impact factor: 4.013

5.  Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II.

Authors:  Pan Wang; Hyoung-Woo Bai; Bao Ting Zhu
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

6.  In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1.

Authors:  Alexey Goltsov; Galina Lebedeva; Ian Humphery-Smith; Gregory Goltsov; Oleg Demin; Igor Goryanin
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-02

7.  Mechanism for the reactivation of the peroxidase activity of human cyclooxygenases: investigation using phenol as a reducing cosubstrate.

Authors:  Chengxi Yang; Peng Li; Xiaoli Ding; Hao Chen Sui; Shun Rao; Chia-Hsiang Hsu; Wing-Por Leung; Gui-Juan Cheng; Pan Wang; Bao Ting Zhu
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.